SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-22-010147
Filing Date
2022-04-25
Accepted
2022-04-25 17:11:57
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2022defa14a.htm DEFA14A 13161
2 votinginstruction1.jpg GRAPHIC 54298
3 votinginstructions2.jpg GRAPHIC 175757
4 votinginstructions3.jpg GRAPHIC 114666
  Complete submission text file 0001628280-22-010147.txt   473129
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38295 | Film No.: 22850580
SIC: 2836 Biological Products, (No Diagnostic Substances)